Chronic vasopressin V(1A) but not V(2) receptor antagonism prevents heart failure in chronically infarcted rats. (Q53962837)

23 May 2018

title

Chronic vasopressin V(1A) but not V(2) receptor antagonism prevents heart failure in chronically infarcted rats. (English)

1 reference

23 May 2018

main subject

AVP

0 references

author name string

Roeland Van Kerckhoven

1

1 reference

23 May 2018

Inge Lankhuizen

2

1 reference

23 May 2018

Richard van Veghel

3

1 reference

23 May 2018

Pramod R Saxena

4

1 reference

23 May 2018

Regien G Schoemaker

5

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 August 2002

1 reference

23 May 2018

European Journal of Pharmacology

published in

1 reference

23 May 2018

volume

449

1 reference

23 May 2018

issue

1-2

1 reference

23 May 2018

page(s)

135-141

1 reference

23 May 2018

Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Vasopressin and a nonpeptide antidiuretic hormone receptor antagonist (OPC-31260)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Increased plasma arginine vasopressin levels in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Regulation of beta-adrenoceptors in a rat model of cardiac failure: effect of perindopril.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Chronic aspirin treatment affects collagen deposition in non-infarcted myocardium during remodeling after coronary artery ligation in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Vascular and renal effects of vasopressin and its antagonists in conscious rats with chronic myocardial infarction; evidence for receptor shift

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Neuroendocrine activation after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Hypertrophic growth of cultured neonatal rat heart cells mediated by vasopressin V(1A) receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Pathophysiology of chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Myocardial infarct size and ventricular function in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Activation of neurohumoral systems following acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Low-dose aspirin improves in vivo hemodynamics in conscious, chronically infarcted rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Binding of [3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Left ventricular energetics: heat production by the human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Some statistical methods useful in circulation research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Vasopressin V2 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901972-6

10.1016/S0014-2999(02)01972-6

7 January 2021

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

12163117

1 reference

23 May 2018